#safety — Wednesday, February 25, 2026 (2 items)
| 0 | 💬 0 |
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naive Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-25 | #vaccination #clinical trial #immunogenicity #safety #pneumococcal | |
| 0 | 💬 0 |
Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-25 | #covid-19 #vaccination #neutralization #immunogenicity #safety |